R&D News | pharmaphorum

News

PureTech begins trial of potential 'Long COVID' drug as case...

As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after the initial infection has been fought off.

News

Pills spilling out of a prescription bottle on 100 dollar paper currency

Swiss start-up Noema raises $59m to develop neurology drugs ...

Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche.

News

Pfizer/BioNTech say COVID-19 vaccine could be approved in Eu...

Pfizer and BioNTech have filed their COVID-19 vaccine with the European medicines regulator, paving the way for a potential approval before the end of the year.

News

Closeup of X-ray photography of human brain

Eisai forges CNS alliance with UK’s Wren Therapeutics

Japanese drugmaker Eisai has teamed up with UK biotech Wren Therapeutics on an R&D programme seeking drugs for neurodegenerative disorders.

News

Biogen bulks up pipeline with Sage drugs in $3bn deal

With the prospects for its Alzheimer’s drug aducanumab still up in the air, Biogen has moved to shore up its late-stage pipeline with a $3 billion licensing deal with Sage that adds drugs f

News

Meadow saffron flowers, Colchicum autumnale, emerging in the autumn from bark mulch with a grass lawn in the background.

Cheap gout drug colchicine added to UK's RECOVERY COVID-19 t...

Colchicine, a cheap and readily available anti-inflammatory drug used to treat diseases such as gout, is to be investigated as a potential therapy for COVID-19 in the UK’s ground-breaking R

PureTech begins trial of potential 'Long COVID' drug as case...

Swiss start-up Noema raises $59m to develop neurology drugs ...

Pfizer/BioNTech say COVID-19 vaccine could be approved in Eu...

Eisai forges CNS alliance with UK’s Wren Therapeutics

Biogen bulks up pipeline with Sage drugs in $3bn deal

Cheap gout drug colchicine added to UK's RECOVERY COVID-19 t...

Why everyone should care about longevity, with Boyang Wang

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks